Evaluating Ketogenic Metabolic Therapies Across Non-Communicable Disease States: A Review Of Current Evidence

19 Jun 2025
Moore
Health Tech , Ketogenic Solutions , Metabolic Health
This presentation reviews the current evidence on ketogenic metabolic therapy (KMT) for managing non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, neurodegenerative disorders, and cancer. It examines KMT's mechanisms, patient outcomes, and disease-specific responses, while identifying knowledge gaps and clinical challenges. Attendees will gain insights into KMT's therapeutic potential and explore its role in improving metabolic health and advancing personalized care for chronic disease management.
Speakers
Dorian Greenow
Dorian Greenow, Founder and President, Keto-Mojo, USA

Hosted By:

Keto-Mojo
Keto-Mojo
Stand: B50